SMA Europe

Latest News

02/04/2020

Euro-NMD launches survey to understand the effects of COVID-19 on people with neuromuscular conditions

01/04/2020

European Medicines Agency grants positive recommendation for conditional marketing authorisation of gene therapy product onasemnogene abeparvovec (Zolgensma®)

25/03/2020
COVID 19 virus

COVID-19

Latest Projects